Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Report: UnitedHealth rewarded nursing homes for delaying hospital transfers
Citing evidence from documents and interviews, the Guardian released an exposé accusing UnitedHealth of directly influencing the day-to-day operations of some 2,000 nursing homes, resulting in patients not receiving necessary emergency care.
FDA wants new heart damage warnings added to COVID-19 vaccines
COVID-19 vaccines are associated with a very low risk of myocarditis and/or pericarditis, primarily in young adults. The long-term impact of this risk has been the subject of many studies and debates over the years; one side says that the benefits of vaccination far outweigh the risks, and the other side says that even the smallest risk of heart damage is too high.
Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs
Researchers explored data from more than 24,000 AVR patients, presenting their findings at EuroPCR in Paris.
Work begins on first ATTR-CM study of its kind
ACT-EARLY is testing the hypothesis that treating asymptomatic carriers of a pathogenic TTR variant with the drug acoramidis could delay amyloidosis from developing.
FDA outlines stricter ‘evidence-based approach’ to COVID vaccinations
The FDA is revising its approach to COVID-19 vaccine approvals, moving away from the previous trend of treating boosters like annual flu shots. Health researcher Vinay Prasad and Commissioner Martin Makary argue in the New England Journal of Medicine for more rigorous data requirements and additional clinical studies to justify future inoculations for those under 65.

19% of heart attack survivors develop heart failure within 5 years

Patients with chronic kidney disease face an especially high risk of developing new-onset heart failure after discharge.

Interventional cardiologists back prior authorization bill, call current policies ‘costly' and ‘time consuming’

The Society for Cardiovascular Angiography and Interventions is the latest industry organization to show its support of the new legislation.

Landmark discovery provides clinicians with a ‘valuable clinical tool’ for diagnosing myocarditis

Researchers believe they have found the first blood biomarker for diagnosing myocarditis, sharing their findings in the New England Journal of Medicine.

Cardiac arrest numbers highlight the pandemic’s long-term impact on patient care

Researchers will be tracking COVID-19's impact on healthcare for many years to come.

Dapagliflozin a cost-effective treatment for HFrEF at its current price point

Researchers found that the SGLT2 inhibitor had similar value among patients with and without diabetes, sharing their findings in JAMA Cardiology.

Cancer patients after PCI: Key statistics every cardiologist should know

Researchers examined data from nearly 1,200 PCI patients, sharing their findings in JACC: Cardiovascular Interventions.

Cardiologist shares a warning fish oil can no longer be considered harmless

After studying the latest research, a veteran cardiologist is no longer recommending fish oil supplements to his patients.

13% of TAVR patients develop acute kidney injury, increasing their risk of in-hospital mortality

Chronic kidney disease, congestive heart failure and liver disease are just some of the comorbidities associated with a greater risk of AKI.

Clinical

Report: UnitedHealth rewarded nursing homes for delaying hospital transfers

FDA wants new heart damage warnings added to COVID-19 vaccines

Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs

Work begins on first ATTR-CM study of its kind

FDA outlines stricter ‘evidence-based approach’ to COVID vaccinations